Cargando…

P07: RESULTS FROM THE CC-220-MM-001 DOSE-EXPANSION PHASE OF IBERDOMIDE PLUS DEXAMETHASONE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA

Detalles Bibliográficos
Autores principales:	van de Donk, N. W. C. J, Popat, R, Hulin, C, Jagannath, S, Oriol, A, Richardson, P. G, Facon, T, Weisel, K, Larsen, J. T, Minnema, M, Abdallah, A, Badros, A. Z, Knop, S, Stadtmauer, E. A, Chen, M, Nguyen, T. V, Amin, A, Peluso, T, Lonial, S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Poster
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9009805/ http://dx.doi.org/10.1097/01.HS9.0000829600.37424.88

Ejemplares similares

High-resolution structures of the bound effectors avadomide (CC-122) and iberdomide (CC-220) highlight advantages and limitations of the MsCI4 soaking system
por: Heim, Christopher, et al.
Publicado: (2022)

P865: BIOMARKER ANALYSIS TO SUPPORT DOSE OPTIMIZATION OF IBERDOMIDE AS MONOTHERAPY AND IN COMBINATION WITH STANDARD OF CARE TREATMENTS FOR MULTIPLE MYELOMA FROM A PHASE 1/2 TRIAL
por: Amatangelo, M., et al.
Publicado: (2022)

Iberdomide (CC-220) is a potent cereblon E3 ligase modulator with antitumor and immunostimulatory activities in lenalidomide- and pomalidomide-resistant multiple myeloma cells with dysregulated CRBN
por: Bjorklund, Chad C., et al.
Publicado: (2019)

P868: MEZIGDOMIDE (MEZI) PLUS DEXAMETHASONE (DEX) IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): RESULTS FROM THE DOSE-EXPANSION PHASE OF THE CC-92480-MM-001 TRIAL
por: Bahlis, Nizar J, et al.
Publicado: (2023)

P1739: HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH TRIPLE-CLASS EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA TREATED WITH IBERDOMIDE PLUS DEXAMETHASONE IN A PHASE 1B/2A OPEN-LABEL DOSE ESCALATION STUDY
por: van de Donk, N. W., et al.
Publicado: (2022)

PB2132: EXCALIBER-RRMM: A PHASE 3, TWO-STAGE STUDY OF IBERDOMIDE, DARATUMUMAB, AND DEXAMETHASONE VERSUS DARATUMUMAB, BORTEZOMIB, AND DEXAMETHASONE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA
por: Lonial, Sagar, et al.
Publicado: (2023)

Biological impact of iberdomide in patients with active systemic lupus erythematosus
por: Lipsky, Peter E, et al.
Publicado: (2022)

CompTIA A+: exams A+ essentials (220-601), 220-602, 220-603, 220-604
por: Brooks, Charles J, et al.
Publicado: (2008)

Iberdomide in patients with systemic lupus erythematosus: a randomised, double-blind, placebo-controlled, ascending-dose, phase 2a study
por: Furie, Richard A, et al.
Publicado: (2022)

Mercurochrome 220 in the Treatment of Malaria
por: Kingsbury, A. Neave, et al.
Publicado: (1925)

CompTIA A+ 220-901 and 220-902
por: Prowse, David L
Publicado: (2016)

CompTIA A+ 220-801 and 220-802
por: Prowse, David L
Publicado: (2013)

CompTIA A+: 220-701 and 220-702
por: Prowse, David L
Publicado: (2011)

Cereblon modulator iberdomide induces degradation of the transcription factors Ikaros and Aiolos: immunomodulation in healthy volunteers and relevance to systemic lupus erythematosus
por: Schafer, Peter H, et al.
Publicado: (2018)

CompTIA A+ complete review guide: exam 220-801, exam 220-802
por: Dulaney, Emmett A, et al.
Publicado: (2012)

CompTIA A+ practice questions: essentials, exams 220-602, 220-603, 220-604
por: Brooks, Charles J
Publicado: (2008)

Mike Meyers' certification passport: CompTIA A+ certification exams 220-901 & 220-902
por: Meyers, Mike, et al.
Publicado: (2016)

CompTIA A+ complete deluxe study guide: exam 220-901, exam 220-902
por: Docter, Quentin, et al.
Publicado: (2016)

'Mercurochrome-220 Soluble' in Leprosy Work
por: Rao, G. R., et al.
Publicado: (1932)

CompTIA A+ 220-901 and 220-902 cert guide
por: Soper, Mark Edward
Publicado: (2017)

CompTIA A+ 220-901 and 220-902: cert guide
por: Soper, Mark Edward
Publicado: (2017)

CompTIA A+ 220-701 and 220-702 cert guide
por: Soper, Mark Edward, et al.
Publicado: (2011)

CompTIA A+ 220-701 and 220-702 practice questions
por: Regan, Patrick E
Publicado: (2011)

CompTIA A+ quick reference (220-701, 220-702)
por: Conry, Ben
Publicado: (2010)

Selektiver Inhibitor des nukleären Exports umgeht Resistenzen beim MM
por: Kempe, Sabrina, et al.
Publicado: (2021)

DEC VT220
Publicado: (1983)

P13: CAN PATIENT-REPORTED OCULAR SYMPTOMS GUIDE DOSE MODIFICATIONS IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA RECEIVING BELANTAMAB MAFODOTIN?
por: Popat, R, et al.
Publicado: (2022)

CompTIA A+ 220-801 and 220-802 authorized cert guide
por: Soper, Mark Edward, et al.
Publicado: (2013)

A Phase 1, Multicenter, Open-Label Study to Evaluate the Pharmacokinetics of Iberdomide in Subjects with Mild, Moderate, or Severe Hepatic Impairment Compared with Healthy Subjects
por: Cheng, Yiming, et al.
Publicado: (2023)

CompTIA A+ certification practice exams: (exams 220-801 & 220-802)
por: Pyles, James, et al.
Publicado: (2013)

CompTIA A+ certification exam guide: exams 220-801 & 220-802
por: Meyers, Michael
Publicado: (2012)

CompTIA A+ certification study guide: exams 220-801 & 220-802
por: Holcombe, Jane, et al.
Publicado: (2013)

CompTIA A+ certification study guide (exams 220-901 & 220-902)
por: Wempen, Faithe, et al.
Publicado: (2017)

CompTIA A+ certification study guide: (exams 220-1001 & 220-1002)
por: Wempen, Faithe, et al.
Publicado: (2019)

CompTIA A+ 220-901 and 220-902 practice questions: exam cram
por: Prowse, David L
Publicado: (2016)

CompTIA® A+® Training Kit (Exam 220-801 and Exam 220-802)
por: Gibson, Darril
Publicado: (2012)

CompTIA A+ rapid review (exam 220-801 and exam 220-802)
por: Gibson, Darril
Publicado: (2013)

CompTIA A+ Complete Study Guide (Exams 220-701 and 220-702)
por: Docter, Quentin, et al.
Publicado: (2009)

CompTIA A+ Complete Review Guide (Exams 220-701/220-702)
por: Dulaney, Emmett
Publicado: (2009)

CompTIA A+ complete study guide: exams 220-801 and 220-802
por: Docter, Quentin, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_cnjtfuvghr0v445l0fcdb0l6ji